An Architecture to Support Graduated Levels of Trust for Cancer Diagnosis with AI

被引:1
|
作者
Rezaeian, Olya [1 ]
Bayrak, Alparslan Emrah [2 ]
Asan, Onur [1 ]
机构
[1] Stevens Inst Technol, Hoboken, NJ 07030 USA
[2] Lehigh Univ, Bethlehem, PA 18015 USA
关键词
Explainablity; Clinical Decision Support Systems (CDSS); Breast Cancer; Trust; Artificial Intelligence (AI); DESIGN;
D O I
10.1007/978-3-031-61966-3_37
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Our research addresses the critical challenge of building trust in Artificial Intelligence (AI) for Clinical Decision Support Systems (CDSS), focusing on breast cancer diagnosis. It is difficult for clinicians to trust AI-generated recommendations due to a lack of explanations by the AI especially when diagnosing life threatening diseases such as breast cancer. To tackle this, we propose a dual-stage AI model combining U-Net architecture for image segmentation and Convolutional Neural Networks (CNN) for cancer prediction. This model operates on breast cancer tissue images and introduces four levels of explainability: basic classification, probability distribution, tumor localization, and advanced tumor localization with varying confidence levels. These levels are designed to offer increasing detail about diagnostic suggestions, aiming to study the effect of different explanation types on clinicians' trust in the AI system. Our methodology encompasses the development of explanation mechanisms and their application in experimental settings to evaluate their impact on enhancing clinician trust in AI. This initiative seeks to bridge the gap between AI capabilities and clinician acceptance by improving the transparency and usefulness of AI in healthcare. Ultimately, our work aims to contribute to better patient outcomes and increased efficiency in healthcare delivery by facilitating the integration of explainable AI into clinical practice.
引用
收藏
页码:344 / 351
页数:8
相关论文
共 50 条
  • [41] Building an AI Support Tool for Real-Time Ulcerative Colitis Diagnosis
    Moller, Bjorn Leth
    Lo, Bobby Zhao Sheng
    Burisch, Johan
    Bendtsen, Flemming
    Vind, Ida
    Ibragimov, Bulat
    Igel, Christian
    KUNSTLICHE INTELLIGENZ, 2024, 38 (03): : 169 - 176
  • [42] The relationship between continuity of care and trust with stage of cancer at diagnosis
    Mainous, AG
    Kern, D
    Hainer, B
    Kneuper-Hall, R
    Stephens, J
    Geesey, ME
    FAMILY MEDICINE, 2004, 36 (01) : 35 - 39
  • [43] The role of AI technology in prediction, diagnosis and treatment of colorectal cancer
    Yu, Chaoran
    Helwig, Ernest Johann
    ARTIFICIAL INTELLIGENCE REVIEW, 2022, 55 (01) : 323 - 343
  • [44] Lung Cancer Diagnosis and Treatment Using AI and Mobile Applications
    Rajesh P.
    Murugan A.
    Muruganantham B.
    Ganesh Kumar S.
    International Journal of Interactive Mobile Technologies, 2020, 14 (17) : 189 - 203
  • [45] AI for prostate cancer diagnosis — hype or today’s reality?
    Ali Bashashati
    S. Larry Goldenberg
    Nature Reviews Urology, 2022, 19 : 261 - 262
  • [46] AI and human interactions in prostate cancer diagnosis using MRI
    Padhani, Anwar R.
    Papanikolaou, Nickolas
    EUROPEAN RADIOLOGY, 2025,
  • [47] Digital medicine Can skin cancer diagnosis be transformed by AI?
    Esteva, Andre
    Topol, Eric
    LANCET, 2019, 394 (10211): : 1795 - 1795
  • [48] AI in Thyroid Cancer Diagnosis: Techniques, Trends, and Future Directions
    Habchi, Yassine
    Himeur, Yassine
    Kheddar, Hamza
    Boukabou, Abdelkrim
    Atalla, Shadi
    Chouchane, Ammar
    Ouamane, Abdelmalik
    Mansoor, Wathiq
    SYSTEMS, 2023, 11 (10):
  • [49] The role of AI technology in prediction, diagnosis and treatment of colorectal cancer
    Chaoran Yu
    Ernest Johann Helwig
    Artificial Intelligence Review, 2022, 55 : 323 - 343
  • [50] AI for prostate cancer diagnosis - hype or today's reality?
    Bashashati, Ali
    Goldenberg, S. Larry
    NATURE REVIEWS UROLOGY, 2022, 19 (05) : 261 - 262